Kelly CRISPR & Gene Editing Technology ETF Rating $7.38 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartOptions ChainRatingsTrends Kelly CRISPR & Gene Editing Technology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XDNA Aggregate RatingModerate Buy 2.71Holdings in XDNA have an aggregate rating of Moderate Buy based on 303 analyst ratings issued in the past year covering 21 companies (94.6% of the portfolio).XDNA Aggregate Price Target$7.38High Prediction$7.38Average Prediction$7.38Low Prediction$7.38Holdings in XDNA have an aggregate price target of $7.38 and a range of $7.38 to $7.38 covering 21 companies (94.6% of the portfolio).XDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Kelly CRISPR & Gene Editing Technology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 XDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings11.05%NTLAIntellia Therapeutics$12.18+0.8%4.2319 of 5 stars2.72$54.94 351.0%18High Trading Volume10.70%TMOThermo Fisher Scientific$524.05+1.4%4.7561 of 5 stars2.86$652.30 24.5%219.57%BEAMBeam Therapeutics$29.01+8.0%3.4396 of 5 stars2.82$47.67 64.3%11Positive NewsHigh Trading Volume8.64%CRSPCRISPR Therapeutics$40.72+0.8%2.5497 of 5 stars2.44$77.93 91.4%18Analyst ForecastHigh Trading Volume6.78%CRBUCaribou Biosciences$1.80-0.6%2.1975 of 5 stars3.00$10.20 466.7%45.63%VERVVerve Therapeutics$5.74+11.2%1.9742 of 5 stars3.00$25.75 348.6%4High Trading Volume5.16%SGMOSangamo Therapeutics$2.47+6.9%1.7507 of 5 stars2.75$7.00 183.4%4Analyst ForecastNews Coverage4.73%PRMEPrime Medicine$2.90+3.9%2.9893 of 5 stars3.00$12.67 336.8%11High Trading Volume4.37%ABBVAbbVie$175.58+2.4%4.9377 of 5 stars2.88$205.70 17.2%24Analyst ForecastInsider TradeHigh Trading Volume4.13%EDITEditas Medicine$1.31-2.2%4.3935 of 5 stars2.07$7.00 434.4%14High Trading Volume4.10%ALLOAllogene Therapeutics$1.87+1.6%2.6638 of 5 stars2.75$9.73 420.5%12Gap DownHigh Trading Volume3.32%PSTXPoseida Therapeutics$9.45+0.4%3.7307 of 5 stars2.00$9.50 0.5%5High Trading Volume2.96%DTILPrecision BioSciences$4.72+2.6%4.4761 of 5 stars3.00$39.50 736.9%2Positive NewsHigh Trading Volume2.87%TSVT2seventy bio$3.14+7.5%2.2126 of 5 stars2.56$9.00 186.6%9Positive News2.40%AAgilent Technologies$134.51+1.0%4.7263 of 5 stars2.43$143.62 6.8%14Analyst ForecastAnalyst RevisionHigh Trading Volume2.10%BMYBristol-Myers Squibb$57.33+1.8%4.6975 of 5 stars2.25$55.64 -2.9%20High Trading Volume2.00%ILMNIllumina$136.02+1.5%4.4818 of 5 stars2.70$165.95 22.0%20High Trading Volume1.53%VRTXVertex Pharmaceuticals$397.27+0.2%4.7494 of 5 stars2.52$499.77 25.8%31Analyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.29%REGNRegeneron Pharmaceuticals$701.85-0.9%4.6604 of 5 stars2.70$1,052.90 50.0%23Analyst ForecastHigh Trading Volume0.69%QGENQiagen$44.67+0.8%3.5234 of 5 stars2.67$51.88 16.1%90.57%BIIBBiogen$146.47-0.6%4.6279 of 5 stars2.45$242.68 65.7%29Analyst DowngradeHigh Trading Volume This page (NASDAQ:XDNA) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kelly CRISPR & Gene Editing Technology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Kelly CRISPR & Gene Editing Technology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
